Inspra and fall Patient Reports February 10, 2012

Inspra Side Effects Report #5130026-4
Inspra side effect was reported by a Physician from GERMANY on Oct 02, 2006. Male patient was diagnosed with cardiac failure congestive and was treated with Inspra. After drug was administered, patient experienced the following side effects: atrial fibrillation , cerebral haemorrhage, confusional state, fall , refusal of treatment by patient, renal failure. Inspra dosage: 25 MG (25 MG, FREQUENCY: DAILY), ORAL. During the same period patient was treated with CARMEN, METOPROLOL TARTRATE, CANDESARTAN, MARCUMAR. Patient was hospitalized. Patient died.

Inspra Side Effects Report #5170364-2
Inspra side effect was reported by a Physician from GERMANY on Nov 27, 2006. Male patient, 80 years of age, weighting 187.4 lb, was diagnosed with cardiac failure and was treated with Inspra. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, dialysis , fall , renal failure, somnolence, traumatic brain injury . Inspra dosage: 25 MG, ORAL. During the same period patient was treated with ANGIOTENSIN II ANTAGONISTS, BETA BLOCKING AGENTS, DIURETICS. Patient died.

Inspra Side Effects Report #5189880-2
Inspra side effect was reported by a Physician from GERMANY on Dec 07, 2006. Male patient, 80 years of age, weighting 187.4 lb, was diagnosed with cardiac failure and was treated with Inspra. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, condition aggravated, dialysis , fall , nephropathy toxic, renal failure chronic, somnolence, traumatic brain injury . Inspra dosage: 25 MG, ORAL. During the same period patient was treated with ANGIOTENSIN II ANTAGONISTS, BETA BLOCKING AGENTS, DIURETICS, ATACAND, MARCUMAR, BISOPROLOL FUMARATE, SIMVASTATIN, NORVASC. Patient died.

Inspra Side Effects Report #5074146-1
Inspra side effect was reported by a Physician from UNITED KINGDOM on July 24, 2006. Male patient, 66 years of age, weighting 134.5 lb, was diagnosed with cardiac failure and was treated with Inspra. After drug was administered, patient experienced the following side effects: cardiac arrest , cardiac disorder, fall , hypertension, hypoaesthesia, hypoxic encephalopathy, paraesthesia, ventricular fibrillation. Inspra dosage: 12.5 MG (12.5 MG, DAILY: EVERY DAY), ORAL. During the same period patient was treated with BUMETANIDE, BENDROFLUMETHIAZIDE, ENALAPRIL MALEATE, NICORANDIL, CLOPIDOGREL, CARVEDILOL, SERETIDE, SALBUTAMOL. Patient died on 05/11/2006.